Results 151 to 160 of about 1,874,188 (207)

Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh: an interim analysis. [PDF]

BMJ Glob Health
Khanam F, Islam MT, Ahmmed F, Rajib MNH, Hossen MI, Chowdhury F, Khan AI, Bhuiyan MTR, Haque S, Biswas PK, Bhuiyan AI, Khan ZH, Amin MA, Rahman A, Rizvi SMS, Shirin T, Islam MN, Tiffany A, Breakwell L, Qadri F, Clemens JD.   +20 more
europepmc   +1 more source

Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool). [PDF]

Hum Vaccin Immunother, 2020
Morgan W, Levin A, Hutubessy RC, Mogasale V.   +3 more
europepmc   +1 more source

Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023. [PDF]

Clin Infect Dis
Edosa M, Jeon Y, Gedefaw A, Hailu D, Mesfin Getachew E, Mogeni OD, Jang GH, Mukasa D, Yeshitela B, Getahun T, Lynch J, Bouhenia M, Worku Demlie Y, Hussen M, Wossen M, Teferi M, Park SE.   +16 more
europepmc   +1 more source

Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019-2020 targeted preventative mass campaigns. [PDF]

Vaccine X
Briskin E, Bateyi Mustafa SH, Mahamba R, Kabunga D, Kubuya J, Porten K, Epicentre-MSF DRC cholera working group, Akilimali L, Okitayemba Welo P, Broban A.   +9 more
europepmc   +1 more source

Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: A matched case-control study

, 2023
Malembaka EB, Bugeme PM, Hutchins C, Xu H, Hulse JD, Demby MN, Gallandat K, Saidi JM, Rumedeka BB, Itongwa M, Tshiwedi-Tsilabia E, Kitoga F, Bodisa-Matamu T, Kavunga-Membo H, Bengehya J, Kulondwa J, Debes AK, Taty N, Lee EC, Lunguya O, Lessler J, Leung DT, Cumming O, Okitayemba PW, Mukadi-Bamuleka D, Knee J, Azman AS.   +26 more
europepmc   +1 more source

Do Oral Cholera Vaccine and Water, Sanitation, and Hygiene Combine to Provide Greater Protection Against Cholera? Results From a Cluster-Randomized Trial of Oral Cholera Vaccine in Kolkata, India. [PDF]

Open Forum Infect Dis
Im J, Islam MT, Ahmmed F, Kim DR, Tadesse BT, Kang S, Khanam F, Chowdhury F, Ahmed T, Firoj MG, Aziz AB, Hoque M, Jeon HJ, Kanungo S, Dutta S, Zaman K, Khan AI, Marks F, Kim JH, Qadri F, Clemens JD.   +20 more
europepmc   +1 more source

Challenges with achieving and maintaining oral cholera vaccine coverage: insights from serial cross-sectional representative surveys in a cholera-endemic community in the Democratic Republic of the Congo. [PDF]

BMJ Public Health
Koyuncu A, Bugeme PM, Dent J, Hutchins C, Xu H, Gallandat K, Cumming O, Matundanya J, Cikomola A, Rukakiza D, Nkombo M, Mufitini JS, Bashige Rumedeka B, Akilimali L, Lee EC, Welo PO, Knee J, Azman AS, Malembaka EB.   +18 more
europepmc   +1 more source

Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti. [PDF]

Int J Infect Dis
Matias WR, Guillaume Y, Cene Augustin G, Vissieres K, Ternier R, Slater DM, Harris JB, Franke MF, Ivers LC.   +8 more
europepmc   +1 more source

Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population. [PDF]

Vaccines (Basel)
Chisenga CC, Phiri B, Ng'ombe H, Muchimba M, Musukuma-Chifulo K, Silwamba S, Laban NM, Luchen C, Liswaniso F, Chibesa K, Mubanga C, Mwape K, Simuyandi M, Cunningham AF, Sack D, Bosomprah S.   +15 more
europepmc   +1 more source

Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study. [PDF]

Lancet Infect Dis
Malembaka EB, Bugeme PM, Hutchins C, Xu H, Hulse JD, Demby MN, Gallandat K, Saidi JM, Rumedeka BB, Itongwa M, Tshiwedi-Tsilabia E, Kitoga F, Bodisa-Matamu T, Kavunga-Membo H, Bengehya J, Kulondwa JC, Debes AK, Taty N, Lee EC, Lunguya O, Lessler J, Leung DT, Cumming O, Okitayemba PW, Mukadi-Bamuleka D, Knee J, Azman AS.   +26 more
europepmc   +1 more source